Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Stays Within Price Pledge, But Average Doesn't Tell The Whole Story, Analyst Says

Executive Summary

Bernstein analyst looks into J&J's average net price decline in 2017 and notes average sales price hikes for growth products Darzalex and Imbruvica are offset by price cuts for drugs facing competition. All products had single digit increases, though.
Advertisement

Related Content

J&J Expects Persistent Pricing Pressure Into 2019
J&J Well Positioned For US Drug Pricing Changes Regardless Of Timing Or Form, Duato Says
Merck's New Pricing Pledge Shows Style Over Substance
As J&J Sees Continued Drug Price Declines, CEO Urges Slow Policy Change Via Trump's Blueprint
As J&J Sees Continued Drug Price Declines, CEO Urges Slow Policy Change Via Trump's Blueprint
How Is Pharma Spending Tax Savings? Not On Drug Pricing, Sen. Booker Says
Janssen Emphasizes Average Net Price Decline As Transparency Momentum Builds In States
J&J Shows Grace Under Pressure From Biosimilars And Other Threats
PhRMA Sues To Block 'Unprecedented' California Price Reporting Law
Fresh From The White House, J&J's Gorsky Talks Policy, Drug Pricing

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100637

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel